A meta-analysis analyzing the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in previously treated patients with non-small cell lung cancer (NSCLC). SVs in targetable genes CH SVs in WBC, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback